Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination.
Clin Appl Thromb Hemost
; 27: 10760296211040110, 2021.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1430348
ABSTRACT
Since the outbreak of Covid-19 in December, 2019, scientists worldwide have been committed to developing COVID-19 vaccines. Only when most people have immunity to SARS-CoV-2, COVID-19 can reduce even wholly overcome. So far, nine kinds of COVID-19 vaccines have passed the phase III clinical trials and have approved for use. At the same time, adverse reactions after COVID-19 vaccination have also reported. This paper focuses on the adverse effects of thrombosis and thrombocytopenia caused by the COVID-19 vaccine, especially the adenovirus-vector vaccine from AstraZeneca and Pfizer, and discusses its mechanism and possible countermeasures.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Trombocitopenia
/
Trombosis
/
Adenoviridae
/
Vacunación
/
Vacunas contra la COVID-19
/
Vectores Genéticos
Tipo de estudio:
Estudio experimental
/
Estudio pronóstico
Tópicos:
Vacunas
Límite:
Humanos
Idioma:
Inglés
Revista:
Clin Appl Thromb Hemost
Asunto de la revista:
Angiología
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
10760296211040110
Similares
MEDLINE
...
LILACS
LIS